Search

everythinglearnresearchcommunity

for

Search:↓

A new staining method shows a special area in the hair's skin layer with lots of proteoglycans.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

The gene Foxn1 is important for hair growth, and understanding it may lead to new alopecia treatments.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

The new treatment was safe and may effectively treat male pattern hair loss.

The treatment increased hair follicle counts and is potentially effective for male hair loss without serious side effects.

The new baby shampoo and wash with stearic acid is safe and potentially effective for nourishing babies' skin.

Hair pulling disorder is treated with therapy and medication; hair loss from tension can be reversed if caught early.

A woman with severe hair loss due to systemic sclerosis regrew her hair in 4 months using a combination of treatments.

Aging causes hair to gray and thin, with the timing of graying varying by race, and factors like oxidative stress and genetics can lead to hair loss.

The document concludes that severe trauma can cause temporary hair loss, known as Telogen Effluvium, which usually resolves without treatment.

Chrysanthemum zawadskii extract may help treat hair loss by promoting hair growth and affecting growth factors.

Skin and hair renewal is maintained by both fast and slow cycling stem cells, with hair regrowth primarily driven by specific stem cells in the hair follicle bulge. These cells can also help heal wounds and potentially treat hair loss.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Some people have severe allergic reactions to anthelminthic drugs, but these are often due to the parasites, not the drugs.

Telomerase-positive cells are mainly in the bulb matrix and outer root sheath of hair follicles.

Hair graying may be caused by stem cell depletion from stress or melanocyte damage.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

A 22-year-old man has alopecia areata, an autoimmune hair loss condition, with various treatments available.

A reliable system was developed to distinguish hair growth stages, aiding in identifying hair growth promoters or inhibitors.

Melanocyte activity in hair follicles is linked to the hair growth cycle, being active in growth phases and inactive in rest phases.

Hair growth can be stimulated by combining certain skin cells, which can rejuvenate old cells and cause them to specialize in hair follicle creation.

Hair follicle cells age faster and lose pigment due to less catalase, causing hair to turn gray.

Plet-1 protein helps hair follicle cells move and stick to tissues.

Targeting Vδ1+T-cells may help treat alopecia areata.

Hair follicle cells become four types: medulla, cortex, cuticle, and inner root sheath.

Nanoparticle-based drug delivery to hair follicles is more effective when tested under conditions that match skin behavior.